Celldex Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $75 | $0 | $730 | $695 |
Gross Profit | 75 | -62,931 | 730 | 695 |
EBITDA | -80,544 | -72,793 | -62,984 | -61,872 |
EBIT | -81,360 | -73,617 | -63,857 | -62,739 |
Net Income | -81,360 | -67,044 | -56,600 | -53,796 |
Net Change In Cash | 75 | 0 | 730 | 695 |
Free Cash Flow | -64,933 | -49,068 | -44,733 | -54,637 |
Cash | 28,871 | 36,037 | 23,044 | 17,136 |
Basic Shares | 66,500 | 66,420 | 66,392 | 66,383 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,500 | $7,020 | $6,883 | $2,357 |
Gross Profit | 1,500 | -156,530 | -111,128 | -79,901 |
EBITDA | -255,420 | -191,901 | -139,034 | -104,200 |
EBIT | -258,800 | -195,078 | -142,042 | -107,096 |
Net Income | -258,800 | -157,863 | -141,429 | -112,325 |
Net Change In Cash | 1,500 | 7,020 | 6,883 | 2,357 |
Free Cash Flow | -213,659 | -159,697 | -109,109 | -105,560 |
Cash | 28,871 | 28,356 | 34,814 | 29,429 |
Basic Shares | 66,500 | 64,395 | 48,449 | 46,888 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.22 |
2025-09-30 | -$1.01 |
2025-06-30 | -$0.85 |
2025-03-31 | -$0.81 |
